Podle toho, jak jsi na tom, ti lékař stanoví nejvhodnější léčbu.3
1 Airaksinen O, et al. Chapter 4. European guidelines for the management of chronic nonspecific low back pain. Eur Spine J. 2006;15(Suppl.2):S192-S300.
2 Hamilton L, Macgregor A, et al. The prevalence of inflammatory back pain in a UK primary cas population. Rheumatology (Oxford) 2014;53:161-4.
3 Airaksinen O, et al. Chapter 4. European guidelines for the management of chronic nonspecific low back pain. Eur Spine J. 2006;15(Suppl. 2):S192–S300.
4 Da Silva JAP, Woolf AD (Eds). Rheumatology in practice. Chapter 11:167-199; Chapter 24:392-405; Chapter 30:506-516; National Institute for Health and Care Excellence (NICE). Adalimumab, etanercept and infliximab for ankylosing spondylitis. May 2008; Albert HB, et al. Antibiotic treatment in patients with chronic low back pain and vertebral bone edema (Modic type 1 changes): a double-blind randomized clinical controlled trial of efficacy. Eur Spine J. 2013;22:697–707.